Racial Disparities in Cardiogenic Shock Outcomes: Single-Center Retrospective Study

Rafik I Issa1, Sarah K Adie2, Vince D Marshall3

  • 1Rafik I. Issa is an internal medicine physician, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.

Insights

Black patients with cardiogenic shock experienced longer hospital stays but similar mortality rates compared to White patients. This study highlights potential disparities in care for Black individuals experiencing cardiogenic shock.

Area of Science:

  • Cardiology
  • Health Services Research
  • Health Equity

Background:

  • Race significantly impacts cardiovascular disease outcomes, but its effect on cardiogenic shock is not well understood.
  • Understanding racial disparities in cardiogenic shock is crucial for equitable patient care.

Purpose of the Study:

  • To investigate the influence of race on outcomes for patients experiencing cardiogenic shock.
  • To identify potential disparities in the management and outcomes of cardiogenic shock across different racial groups.

Main Methods:

  • A retrospective cohort study analyzed 2458 adult patients admitted for cardiogenic shock between June 2019 and June 2023.
  • Patients were categorized into White, Black, and other racial groups for comparative analysis.
  • Propensity score weighting was employed to compare mortality, length of stay, and mechanical support use.

Main Results:

  • Black patients were younger, had higher Sequential Organ Failure Assessment scores, and were more likely to be admitted from inpatient wards.
  • No significant differences in hospital or cardiac intensive care unit mortality were observed between racial groups.
  • Black patients experienced significantly longer hospital and cardiac intensive care unit stays compared to White patients.

Conclusions:

  • While mortality rates were similar, longer lengths of stay for Black patients suggest potential disparities in clinical management.
  • Further research is needed to address and rectify inequities in cardiogenic shock care.
  • These findings underscore the importance of examining race in cardiovascular outcomes research.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52